Regulatory investigations in the aesthetics industry

Call 0345 872 6666

‌

Regulatory investigations in the aesthetics industry

The aesthetics industry in England is subject to growing regulatory scrutiny. There is not yet one regulatory framework covering all non-surgical cosmetic procedures, but some treatments are regulated and aesthetic practitioners and businesses can face investigations and enforcement action. In all cases, those who perform aesthetic procedures must comply with age restrictions, advertising rules and local authority powers. They should also determine whether they need to register with the Care Quality Commission (CQC) or comply with Medicines and Healthcare products Regulatory Agency (MHRA) requirements.

An investigation may begin after a patient complaint, an adverse event, concerns about a product, an inspection or a referral from another regulatory body. For an aesthetic practice, the consequences of non-compliance can affect your professional registration, reputation and the ability to continue providing aesthetic treatments.

In this blog, the experienced aesthetic regulation solicitors at JMW explain what can trigger an investigation, which regulatory bodies may become involved and how practitioners who provide aesthetic medicine or non-surgical aesthetic procedures can protect their position.

What regulations currently apply to non-surgical cosmetic procedures in England?

Regulation of non-surgical cosmetic procedures is currently inconsistent, and the rules depend on the treatment, product, practitioner and whether the activity falls within an existing regulated healthcare framework. Further, the laws in this area are developing at a rapid pace. As such, it can be difficult for providers to determine where their activity falls and how to meet their legal obligations.

Section 180 Health and Care Act 2022 provides powers to introduce a licensing scheme requiring practitioners and the premises to be licensed for specified non-surgical procedures. However, the introduction and detailed requirements of that scheme depend on further regulations. The CQC regulates certain activities under the Health and Social Care Act 2008. Whether registration is required depends on the nature and purpose of the treatment, the circumstances in which it is provided, and whether it falls within a regulated activity under the Health and Social Care 2008 (Regulated Activities) Regulations 2014.

However, some rules are clear and apply in a straightforward way. Some products that are used in non-surgical cosmetic treatments are prescription-only medicines, including products such as botulinum toxin (Botox) and weight loss medicine. Their prescribing, sale, supply and administration are subject to strict legal requirements. The MHRA can investigate unlawful supply, promotion or use of unlicensed products.

The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes it a criminal offence in England to administer botulinum toxin or cosmetic fillers by injection to someone under 18, subject to limited statutory defences relating to arrangements made by persons carrying on businesses.

Meanwhile, regulated healthcare professionals who provide non-surgical aesthetic treatments will be bound by the regulations of bodies such as the General Medical Council, General Dental Council or General Pharmaceutical Council.

Close up of beautician expert's hands injecting botox in female forehead. 

What can trigger a regulatory investigation into an aesthetic practice?

The role of regulatory oversight in your practice will depend on whether you are registered with a particular regulator and the types of procedures you carry out. Typically, investigations are triggered by complaints from patients, referrals from competitors, or evidence gathered during unrelated investigations. This may relate to a single incident or a pattern of conduct, and an investigation may involve more than one body, depending on the nature of the concern. Depending on the issue, relevant regulatory bodies may include:

  • The MHRA - for medicines, medical devices, product provenance or unlawful promotion of prescription-only medicines.
  • The CQC - if an aesthetic practice carries on a regulated activity requiring registration.
  • Professional regulators - in cases where the conduct or fitness to practise of regulated healthcare professionals is questioned.
  • Local authorities and Trading Standards - when local licensing, age restrictions, consumer protection or other statutory enforcement powers apply.
  • The Advertising Standards Authority - if marketing for cosmetic procedures breaches advertising rules.

Where concerns are raised about patient safety, the professional conduct of cosmetic practitioners and possible violations of medicines law, regulatory investigations may take place in parallel with criminal proceedings.

Common triggers that may warrant investigation include:

  • Unlicensed or counterfeit products sourced from unsuitable suppliers. Unfortunately, supply chain issues in the UK make this a significant risk, and clinics must carry out thorough due diligence on supplier relationships to prevent the risk of supplying counterfeit products. This can create serious patient safety issues and potential criminal liability, so investigations often include multiple bodies.
  • Concerns about how prescription-only medicines were obtained, prescribed, supplied or administered, particularly where an aesthetic clinic has governance issues, responsibilities are not clearly delineated or clinical judgement is not deemed to be impartial.
  • Serious complications following aesthetic procedures, particularly where they result in complaints or referrals.
  • Poor hygiene, unsuitable premises or weak infection-control procedures.
  • Issues with consent and records. Regulated healthcare professionals are expected to obtain informed consent and keep appropriate treatment records for certain treatments. The General Medical Council's guidance on cosmetic interventions also addresses competence, patient information, psychological needs and responsible marketing.
  • Non-compliance with advertising standards. Advertising prescription-only medicines to the public is prohibited under the Human Medicines Regulations 2012. Breaches may result in regulatory enforcement, including action by the MHRA, whilst none-compliant advertising may be investigated by the Advertising Standards Authority. Read more here about the MHRA’s expanded criminal enforcement capacity.
  • Age restrictions. Supplying prohibited treatments to under-18s can lead to enforcement action.

You should seek legal advice from an experienced regulatory investigation solicitor if you are notified about a complaint or that an investigation is due to take place. Your response to the investigation can make a big difference to the outcome, and early legal intervention can minimise disruption for aesthetic practitioners providing non-surgical treatments.

What happens during a regulatory investigation?

The investigation process depends on the regulator and the legal powers being used. In general, the procedures aim to gather evidence, determine whether there is scope to take regulatory enforcement action (or launch criminal proceedings), and address the concern as thoroughly as possible.

While there is no set process, most investigations will involve:

  1. An initial complaint, referral or inspection: Information may come from a patient, employee, another healthcare professional, another authority or the regulator's own monitoring.
  2. Requests for documents: A regulator may seek treatment records, consent forms, training certificates, prescribing records, supplier information, product batch details or evidence of indemnity cover.
  3. Inspection and evidence gathering: Where the regulator has the necessary powers, it may inspect premises, examine products or equipment, or obtain documents and digital material.
  4. Interviews: Individuals may be asked to provide information or attend an interview. Where criminal offences are suspected, this may include an interview under caution.
  5. Enforcement or referral: Outcomes can range from no further action or advice to professional disciplinary proceedings, restrictions, civil enforcement or criminal prosecution. Information may also be passed to another regulatory body.

During any investigations in the aesthetics sector, businesses and individuals have the right to legal support. The regulatory investigation solicitors at JMW can help you to comply with the investigation, challenge evidence and mount a strong defence on your behalf. This is vital, as the ways in which an aesthetic practice responds at the start can affect what happens next. Practitioners should take the enquiry seriously without making rushed admissions or providing an unstructured response. You should:

  • Preserve records. Do not amend, delete or recreate treatment notes, messages or product records once an investigation is anticipated.
  • Establish the legal basis for any demand for documents, entry to premises or interview.
  • Retain supplier details, batch numbers, prescriptions and other traceability information for aesthetic treatments or products.
  • Review clinical documentation. Records should show consultation, informed consent, treatment decisions, aftercare and adverse events.
  • Coordinate parallel investigations, where several regulatory bodies are involved. Responses should be consistent and carefully managed. A solicitor can support you and develop written responses that, in many cases, can lead to no further action being taken.

Our experts can also advise you on compliance and the regulatory and legal framework that applies to your practice based on the specific procedures or treatments you offer. This supports compliance and will minimise the risk of aesthetics and medical professionals facing enforcement action or regulatory investigations.

How can JMW help with an aesthetics regulatory investigation?

Regulatory investigations can place an aesthetic practice, its owners and individual practitioners under significant pressure. With the UK government planning a new licensing scheme for high-risk procedures and changes to relevant oversight frameworks for regulators, compliance is also set to become more challenging.

JMW's aesthetic regulation solicitors advise aesthetic practitioners and businesses on regulatory compliance, criminal investigations, professional proceedings and CQC-related issues. Our regulatory team can also help where an investigation involves several bodies or creates wider commercial and reputational risks. Our up-to-date knowledge of the Health and Care Act 2022 can also support long-term compliance ahead of any planned changes.

The powers available to regulators vary depending on the legislation under which they are acting. It is important to distinguish between voluntary requests for information and those made under statutory powers, particularly where to comply may constitute a criminal offence.

The same underlying conduct may give rise to separate criminal, regulatory and professional disciplinary proceedings. We can assist with the different legal tests, procedures and potential sanctions these might entail.

If you have been contacted by a regulator, or are concerned an incident could lead to an investigation, call JMW on 0345 872 6666 or complete our online enquiry form to discuss your circumstances.

Did you find this post interesting? Share it on:

Related Posts